hotspot -WSS

hotspot

author：entertainment 2025-09-06 01:58:45 - browse：7954

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Devoted Health’s losses in Medicare Advantage persist

WSS

FDA seeks to regulate lab

Shingles, which affected Dianne Feinstein, is on the rise

Did you have Obamacare on your GOP debate bingo card?

Problems with a popular proposal to regulate AI in health care

Would Medicare drug price negotiations stall in a shutdown?

Would Medicare drug price negotiations stall in a shutdown?

hotspot

hotspot

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Why do women spend more than men on medical expenses?

How to save PrEP access — and even expand it

The CDC's new social media misinformation war

As demand for Covid shots wanes, Moderna seeks its next success

Surgery pushed Ben Carson to fame

BioMarin wins approval for gene therapy to treat hemophilia A

FDA advisers vote against ALS treatment from BrainStorm

Activists slam private health insurers over coverage restrictions

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

hotspot

Padmanee Sharma of MD Anderson at center of lawsuit over credit

The CDC's new social media misinformation war

Cano Health’s bankruptcy is a warning for Medicare Advantage

Ionis has late

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Johnson & Johnson sued for allegedly overpaying for workers' drugs

leisure time

focus

hotspot

Wikipedia